Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma.

Amsbaugh MJ, Mahajan A, Thall PF, McAleer MF, Paulino AC, Grosshans D, Khatua S, Ketonen L, Fontanilla H, McGovern SL.

Int J Radiat Oncol Biol Phys. 2019 Jan 2. pii: S0360-3016(18)34225-1. doi: 10.1016/j.ijrobp.2018.12.043. [Epub ahead of print]

PMID:
30610915
2.

Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.

Freese C, Takiar V, Fouladi M, DeWire M, Breneman J, Pater L.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):86-92. doi: 10.1016/j.prro.2016.11.005. Epub 2016 Nov 23. Review.

PMID:
28274399
3.

Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis.

Lu VM, Welby JP, Mahajan A, Laack NN, Daniels DJ.

Childs Nerv Syst. 2019 Mar 16. doi: 10.1007/s00381-019-04118-y. [Epub ahead of print] Review.

PMID:
30879125
4.

Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.

Kline C, Liu SJ, Duriseti S, Banerjee A, Nicolaides T, Raber S, Gupta N, Haas-Kogan D, Braunstein S, Mueller S.

J Neurooncol. 2018 Dec;140(3):629-638. doi: 10.1007/s11060-018-2991-5. Epub 2018 Sep 11.

PMID:
30206764
5.

Palliative reirradiation for progressive diffuse intrinsic pontine glioma.

Fontanilla HP, Pinnix CC, Ketonen LM, Woo SY, Vats TS, Rytting ME, Wolff JE, Mahajan A.

Am J Clin Oncol. 2012 Feb;35(1):51-7. doi: 10.1097/COC.0b013e318201a2b7.

PMID:
21297433
6.

Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage.

Shen CJ, Kummerlowe MN, Redmond KJ, Martinez-Gutierrez JC, Usama SM, Holdhoff M, Grossman SA, Laterra JJ, Strowd RE, Kleinberg LR.

Adv Radiat Oncol. 2018 Jul 10;3(4):582-590. doi: 10.1016/j.adro.2018.06.005. eCollection 2018 Oct-Dec.

7.

Thoracic reirradiation for lung cancer: a literature review and practical guide.

Drodge CS, Ghosh S, Fairchild A.

Ann Palliat Med. 2014 Apr;3(2):75-91. doi: 10.3978/j.issn.2224-5820.2014.03.04.

8.

3D conformal radiotherapy and cisplatin for recurrent malignant glioma.

VanderSpek L, Fisher B, Bauman G, Macdonald D.

Can J Neurol Sci. 2008 Mar;35(1):57-64.

PMID:
18380278
9.

Reirradiation for locoregionally recurrent lung cancer: outcomes in small cell and non-small cell lung carcinoma.

Kruser TJ, McCabe BP, Mehta MP, Khuntia D, Campbell TC, Geye HM, Cannon GM.

Am J Clin Oncol. 2014 Feb;37(1):70-6. doi: 10.1097/COC.0b013e31826b9950.

10.

Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma.

Back M, Gzell CE, Kastelan M, Guo L, Wheeler HR.

Neurooncol Pract. 2015 Mar;2(1):48-53. Epub 2014 Dec 15.

11.

A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.

Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1182-5.

PMID:
12654425
12.

Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.

Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Haque S, Zanzonico P, Carrasquillo JA, Lyashchenko SK, Thakur SB, Donzelli M, Turner RS, Lewis JS, Cheung NV, Larson SM, Dunkel IJ.

Lancet Oncol. 2018 Aug;19(8):1040-1050. doi: 10.1016/S1470-2045(18)30322-X. Epub 2018 Jun 18. Erratum in: Lancet Oncol. 2018 Aug;19(8):e382.

PMID:
29914796
13.

Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.

Janssens GO, Gandola L, Bolle S, Mandeville H, Ramos-Albiac M, van Beek K, Benghiat H, Hoeben B, Morales La Madrid A, Kortmann RD, Hargrave D, Menten J, Pecori E, Biassoni V, von Bueren AO, van Vuurden DG, Massimino M, Sturm D, Peters M, Kramm CM.

Eur J Cancer. 2017 Mar;73:38-47. doi: 10.1016/j.ejca.2016.12.007. Epub 2017 Feb 3.

PMID:
28161497
14.

Three-dimensional conformal reirradiation for locoregionally recurrent lung cancer previously treated with radiation therapy.

Huh GJ, Jang SS, Park SY, Seo JH, Cho EY, Park JC, Yang YJ.

Thorac Cancer. 2014 Jul;5(4):281-8. doi: 10.1111/1759-7714.12089. Epub 2014 Jul 3.

15.

Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group.

Müller K, Scheithauer H, Pietschmann S, Hoffmann M, Rössler J, Graf N, Baumert BG, Christiansen H, Kortmann RD, Kramm CM, von Bueren AO.

Radiat Oncol. 2014 Aug 12;9:177. doi: 10.1186/1748-717X-9-177.

16.

Reirradiation of recurrent breast cancer with and without concurrent chemotherapy.

Würschmidt F, Dahle J, Petersen C, Wenzel C, Kretschmer M, Bastian C.

Radiat Oncol. 2008 Sep 18;3:28. doi: 10.1186/1748-717X-3-28.

17.

Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapy.

Margalit DN, Schoenfeld JD, Rawal B, Haddad RI, Catalano PJ, Goguen LA, Chau NG, Rabinowits G, Lorch JH, Annino DJ, Tishler RB.

Oral Oncol. 2017 Oct;73:160-165. doi: 10.1016/j.oraloncology.2017.08.012. Epub 2017 Sep 8.

PMID:
28939070
18.

Reirradiation for locally recurrent lung cancer previously treated with radiation therapy.

Okamoto Y, Murakami M, Yoden E, Sasaki R, Okuno Y, Nakajima T, Kuroda Y.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):390-6.

PMID:
11872284
19.

How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?

Teo PM, Kwan WH, Chan AT, Lee WY, King WW, Mok CO.

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):897-913. Review.

PMID:
9531376
20.

Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience.

Lassaletta A, Strother D, Laperriere N, Hukin J, Vanan MI, Goddard K, Lafay-Cousin L, Johnston DL, Zelcer S, Zapotocky M, Rajagopal R, Ramaswamy V, Hawkins C, Tabori U, Huang A, Bartels U, Bouffet E.

Pediatr Blood Cancer. 2018 Jun;65(6):e26988. doi: 10.1002/pbc.26988. Epub 2018 Jan 25.

PMID:
29369515

Supplemental Content

Support Center